Clinical Trial Update: Atezolizumab Plus Bevacizumab With HCC and HBV Infection [NA]

View source ↗

Summary

Clinical trial update on atezolizumab plus bevacizumab for hepatocellular carcinoma, including patients with HBV infection. The study (NCT04180072) is currently…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avastin (bevacizumab)
• Tecentriq (atezolizumab)

Snippet

Sponsor: National Health Research Institutes, Taiwan | Conditions: Carcinoma, Hepatocellular | NA | Status: ACTIVE_NOT_RECRUITING